SCHEMBL6781014

SCHEMBL6781014

CCCCOc1ccc(N(C)CC2(O)CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.52
MMP9 P14780 3/20 0.52
MMP13 P45452 3/20 0.52
ADAM17 P78536 3/20 0.52
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
TSHR P16473 1/20 0.49
RAB9A P51151 4/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP2D6 P10635 1/20 0.48
NPC1 O15118 4/20 0.46
TP53 P04637 3/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
S1PR5 Q9H228 1/20 0.45
KDM4E B2RXH2 2/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HRH3 Q9Y5N1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6780352 0.99 MMP1 (0.51) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL6783586 0.89 MMP1 (0.50) MMP1MMP9MMP13ADAM17KMT2A
Hydrochloric Acid SCHEMBL6784819 0.89 MMP1 (0.49) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL6780311 0.88 MMP1 (0.48) MMP1MMP9MMP13ADAM17KMT2A
Hydrochloric Acid SCHEMBL6783603 0.87 MMP1 (0.48) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL6784583 0.85 FAAH (0.46) MMP1MMP9MMP13ADAM17KMT2A
Hydrochloric Acid SCHEMBL6779450 0.84 FAAH (0.45) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL6899749 0.83 FAAH (0.47) MMP1MMP9MMP13ADAM17TSHR
SCHEMBL6784170 0.83 KMT2A (0.54) MMP1MMP9MMP13ADAM17KMT2A
SCHEMBL6782840 0.83 MMP1 (0.48) MMP1MMP9MMP13ADAM17KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710060-B2 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2004-03-23 US disclosed
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-12-12 US disclosed
EP-1182192-A1 4-HYDROXYPIPERIDINE DERIVATIVES HAVING ANTIARRHYTHMIC EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity SCN5A, RYR2, SCN1B MMP1 1180/4885MMP9 1184/4885MMP13 3448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.